dihexa cancer risk c-met hgf HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth – Dihexa targets neurotrophic factors like
Dihexa targets neurotrophic factors like BDNF and NGF, which drive brain repair. By activating the c MET receptor, it helps cells take in nutrients and rebuildespecially in cases where recovery is Dihexa Side Effects: The No Human Data Reality (2026) Targeting of c MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma: Cell Reports Medicine Dihexa: Enhancing Cognitive Function Effectively Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31



